glpg1205
Small moleculeexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT01887106)
Timeline
Indications
Mechanism of action
- G-protein coupled receptor 84MODULATOR
GPR84 modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- glpg1205
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04704739 | Phase 1 | Jan 13, 2021 | Galapagos NV |
| NCT04532567 | Phase 1 | Aug 18, 2020 | Galapagos NV |
| NCT03725852 | Phase 2 | Sep 27, 2018 | Galapagos NV |
| NCT03102567 | Phase 1 | Oct 18, 2016 | Galapagos NV |
| NCT02623296 | Phase 1 | Oct 1, 2015 | Galapagos NV |
| NCT02337608 | Phase 2 | Dec 1, 2014 | Galapagos NV |
| NCT02143856 | Phase 1 | May 1, 2014 | Galapagos NV |
| NCT01887106 | Phase 1 | Jun 1, 2013 | Galapagos NV |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galapagos NV | For profit | 8 | 8 | 2 | 2013 |
1 organizations
Page 1 / 1